“Perspectives on Patient-Focused Drug Development in Rare Disease”

In the field of rare disease, placing patients at the center of drug development is critical but complex.

This webinar provides an in-depth look at the essential role of patient-focused drug development (PFDD) and its unique challenges in the rare disease landscape. Led by Zizi Uzezi Imatorbhebhe, Senior VP of Global Strategy & Development in Rare Disease, and patient advocate Ella Balasa, this session offers valuable insights from both industry and patient perspectives.

Key Takeaways Include:

Importance of PFDD and regulatory support
Benefits of integrating patient insights into drug development
Overcoming challenges in patient involvement for rare diseases

"*" indicates required fields

Please enter your details to get access to the resource

First Name*

Last Name*

Job Title

Industry*

Company*

Email*

Telephone

By submitting this form, you consent to your personal data submitted in the form being processed in alignment with our Online Privacy and Cookies policy. Your personal data will be processed to facilitate your request and may be used for sending you additional marketing and business development-related information about Ergomed, its affiliates, and our services. You can withdraw your consent anytime by messaging marketing@ergomedgroup.com, and we will promptly remove your data from our records. For more information about how we will process your personal data and your rights, please see our Online Privacy and Cookies policy.

Phone

This field is for validation purposes and should be left unchanged.

Enter a term to search

Perspectives on Patient-Focused Drug Development in Rare Disease

In the field of rare disease, placing patients at the center of drug development is critical but complex.

Please enter your details to get access to the resource